PHARMACEUTICAL COMPOSITION CONTAINING HISTONE DEACETYLASE INHIBITOR
An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance. Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo deri...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English Serbian |
| Published |
04.04.2008
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance.
Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo derivata benzamida, kao što N-(2-aminofenil)-4-[N-(piridin-3-ilmetoksikarbonil)aminoetil]benzamid (MS-275), koji je inhibitor histonske deacetilaze, prilikom kombinovane upotrebe sa još jednom aktivnom antikancerskom supstancom. |
|---|---|
| AbstractList | An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance.
Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo derivata benzamida, kao što N-(2-aminofenil)-4-[N-(piridin-3-ilmetoksikarbonil)aminoetil]benzamid (MS-275), koji je inhibitor histonske deacetilaze, prilikom kombinovane upotrebe sa još jednom aktivnom antikancerskom supstancom. |
| Author | MIGITA HIDEYUKI SUGAWARA TAISUO NAKANISHI OSAMU MATSUBA YASUHIRO |
| Author_xml | – fullname: NAKANISHI OSAMU – fullname: MIGITA HIDEYUKI – fullname: SUGAWARA TAISUO – fullname: MATSUBA YASUHIRO |
| BookMark | eNrjYmDJy89L5WRwDvBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcDsv1CHD39PP3cFTw8g0P8_VwVXFyBSkMifRyDXRU8_Tw8nTxD_IN4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8ULCRgYGpgYWFiaMxEUoAKlktaw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | FARMACEUTSKI PREPARAT KOJI SADRŽI INHIBITOR HISTONSKE DEACETILAZE |
| ExternalDocumentID | RS20050884A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_RS20050884A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:55:29 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Serbian |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_RS20050884A3 |
| Notes | Application Number: YU2005P000884 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080404&DB=EPODOC&CC=RS&NR=20050884A |
| ParticipantIDs | epo_espacenet_RS20050884A |
| PublicationCentury | 2000 |
| PublicationDate | 20080404 |
| PublicationDateYYYYMMDD | 2008-04-04 |
| PublicationDate_xml | – month: 04 year: 2008 text: 20080404 day: 04 |
| PublicationDecade | 2000 |
| PublicationYear | 2008 |
| RelatedCompanies | SCHERING AKTIENGESELLSCHAFT |
| RelatedCompanies_xml | – name: SCHERING AKTIENGESELLSCHAFT |
| Score | 2.6908557 |
| Snippet | An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl)... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | PHARMACEUTICAL COMPOSITION CONTAINING HISTONE DEACETYLASE INHIBITOR |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080404&DB=EPODOC&locale=&CC=RS&NR=20050884A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOpNUQN-ZQez2yKRrW4HYkZXXI3rlq0YPJG1GwkXIDDjv287Ab3orWmbl9emr6_v61eAO0fmPZRLHWT1hGXnXdvypFtYzjR3UCGlLZCuRo4YCkf2y9gZN2C2rYWpcUI_a3BEJVFSyXtV39fLHydWUOdWru_FTHUtnoa8H5hb69hVZ9I2g0GfJHEQYxPjfpqZLK0RN5VA2f4e7OtXtIbZJ28DXZSy_K1RhidwkChi8-oUGutVC47w9uO1FhxGm3i3am5Eb30GOAn9NPIxGXENYWDgOErijGoPk2oz7lNG2bMR0ozHjBgBUVP5-6ufEYOykA4oj9NzMIaE49BS3Ex2K5-k2Y7v3gU054t52QZDuKiH3MITEpXaPMtF-dAtii6S00evdMoOdP4kc_nP2BUcf2dD6NSUa2hWq4_yRqncStzWm_UF4MWBKg |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOJNUSN-7mB2WySyle1AzOiGq7Ju2YrBE1m7kXABAjP--7YT0IvemrZ5eW36-vq-fgW4t0TWQZlQQVaHG2bWNg1H2LlhTTML5UKYHKlq5JCiYGS-jK1xDWbbWpgKJ_SzAkeUEiWkvJfVfb38cWJ5VW7l-oHPZNfiacB6nr61jm15Jk3d6_f8OPIirGPcS1KdJhXiphQo092D_a4C51Uvp7e-KkpZ_tYog2M4iCWxeXkCtfWqCQ28_XitCYfhJt4tmxvRW58CjgM3CV3sj5iCMNBwFMZRSpSHSbYpcwkl9FkLSMoi6mueL6ey96Gb-hqhAekTFiVnoA18hgNDcjPZrXySpDu-O-dQny_mxQVo3EYdZOcOF6hQ5lnGi8d2nreRmHadwipa0PqTzOU_Y3fQCFg4nAwJfb2Co-_MCJWmcg31cvVR3Ej1W_LbauO-ABOqhBc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+CONTAINING+HISTONE+DEACETYLASE+INHIBITOR&rft.inventor=NAKANISHI+OSAMU&rft.inventor=MIGITA+HIDEYUKI&rft.inventor=SUGAWARA+TAISUO&rft.inventor=MATSUBA+YASUHIRO&rft.date=2008-04-04&rft.externalDBID=A&rft.externalDocID=RS20050884A |